FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> WHO | swine flu

Critics deride WHO's ties to vaccine industry

Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!



Tools
  • Subscribe
  • Email
  • Print
  • Contact Author
  • Reprint

Five of the 15 experts who sat on the WHO's emergency swine flu panel had financial ties to the drug industry, stirring fresh accusations that the group helped spur huge profits for drug companies like GlaxoSmithKline by whipping up a global frenzy over the H1N1 pandemic. WHO officials have steadfastly denied that financial considerations played any role in the pandemic declaration, which helped create a multibillion-dollar market for Big Pharma. Story


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:

More stories about WHO   swine flu